RVOT Anomaly clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
Sorry, in progress, not accepting new patients
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™ TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony TPV.
at UCLA
Our lead scientists for RVOT Anomaly research studies include Daniel Levi.
Last updated: